Hypersomatotropism in pregnant women, as measured by a human liver radioreceptor assay.

Radioreceptor assays (RRAs) provide useful information about the bioactivity of peptide hormones. We have developed a RRA for human GH using membranes prepared from human liver. The assay has 1% cross-reactivity with human PRL, 0.11% cross-reactivity with human chorionic somatomammotropin, and negligible cross-reactivity with bovine and rat GH. The assay has distinct advantages over the IM-9 lymphocyte RRA in having reduced nonspecific interference from serum proteins and providing a uniform source of receptors which can be stored for long periods at -70 C. The coefficient of variation of the assay is 13%. In studies of 55 sera from short children with normal or elevated serum GH concentrations the mean ratio of RRA GH to immunoradiometric assayed GH was 1.28. This assay provided important information about the total GH activity in pregnancy. There was a progressive rise in RRA GH during pregnancy, reaching 64.7 +/- 2.5 (+/- SE) micrograms/L at term. This level is 2-3 times higher than suggested by earlier estimates made with monoclonal antibody RIAs for pituitary GH. At term the contributions to total GH activity of serum are less than 3% from the pituitary, 12% from human chorionic somatomammotropin reacting with the GH receptor, and 85% from placental GH. Despite this great increase in receptor-reactive GH, somatomedin activity by bioassay is reduced, and IGF-I, determined by RIA after acid-gel filtration, is minimally elevated.

[1]  B. Sherman,et al.  Variability in the quantitation of circulating growth hormone using commercial immunoassays. , 1989, The Journal of clinical endocrinology and metabolism.

[2]  A. Barkan,et al.  Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. , 1988, The Journal of clinical endocrinology and metabolism.

[3]  S. Liebhaber,et al.  Two distinct species of human growth hormone-variant mRNA in the human placenta predict the expression of novel growth hormone proteins. , 1988, The Journal of biological chemistry.

[4]  W. Daughaday,et al.  Specific immunoradiometric assay of insulin-like growth factor I with use of monoclonal antibodies. , 1987, Clinical chemistry.

[5]  W. Daughaday,et al.  Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Handwerger,et al.  A unique placental lactogen receptor: implications for fetal growth. , 1987, Endocrinology.

[7]  J. Martial,et al.  Expression of the growth hormone variant gene in human placenta. , 1987, The Journal of clinical endocrinology and metabolism.

[8]  R. Baxter,et al.  Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma. , 1986, The Journal of clinical investigation.

[9]  S. Handwerger,et al.  The glycogenic effects of placental lactogen and growth hormone in ovine fetal liver are mediated through binding to specific fetal ovine placental lactogen receptors. , 1986, Endocrinology.

[10]  N. Samaan,et al.  Nonsuppressible insulin-like activity and somatomedin C levels in normal pregnant women, in pregnant women with gestational diabetes, and in umbilical cord blood of mature and premature infants. , 1985, American journal of obstetrics and gynecology.

[11]  B. Posner,et al.  Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal, and adult sera. , 1984, The Journal of clinical endocrinology and metabolism.

[12]  K. Hall,et al.  Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. , 1984, The Journal of clinical endocrinology and metabolism.

[13]  L. Lazarus,et al.  Identification and characterization of specific growth hormone receptors in cultured human fibroblasts. , 1983, The Journal of clinical endocrinology and metabolism.

[14]  D. Wilson,et al.  Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. , 1982, The Journal of clinical endocrinology and metabolism.

[15]  W. Daughaday,et al.  Homologous IM-9 lymphocyte radioreceptor and receptor modulation assays for human serum growth hormone. , 1982, The Journal of clinical endocrinology and metabolism.

[16]  A. Leung,et al.  Serum immunoreactive somatomedin levels in normal adults, pregnant women at term, children at various ages, and children with constitutionally delayed growth. , 1981, The Journal of clinical endocrinology and metabolism.

[17]  D. Clemmons,et al.  Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status. , 1980, The American journal of medicine.

[18]  P. Lebech,et al.  SOMATOMEDIN IN NEWBORNS AND THE RELATIONSHIP TO HUMAN CHORIONIC SOMATOTROPIN AND FETAL GROWTH , 1978, Acta paediatrica Scandinavica.

[19]  S. Handwerger,et al.  Serum immunoreactive somatomedin-C is elevated late in pregnancy. , 1978, The Journal of clinical endocrinology and metabolism.

[20]  R. Hintz,et al.  Somatomedin and growth hormone in the newborn. , 1977 .

[21]  P. Gorden,et al.  Reactivity of non-primate growth hormones and prolactins with human growth hormone receptors on cultured human lymphocytes. , 1977, Journal of Clinical Endocrinology and Metabolism.

[22]  A. Frantz,et al.  Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man. , 1976, The Journal of clinical endocrinology and metabolism.

[23]  H. Friesen,et al.  Growth hormone and insulin binding to human liver. , 1976, The Journal of clinical endocrinology and metabolism.

[24]  Z. Laron,et al.  Human growth hormone receptors in human circulating lymphocytes. , 1975, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[25]  L. Tatò,et al.  Early variations of plasma somatomedin activity in the newborn. , 1975, The Journal of clinical endocrinology and metabolism.

[26]  L. Chesley.  Growth hormone activity in human pregnancy. I. Serum sulfation factor. , 1962, American journal of obstetrics and gynecology.

[27]  W. Daughaday,et al.  Sulfation factor activity of sera from patients with pituitary disorders. , 1959, The Journal of clinical endocrinology and metabolism.

[28]  A. Morris,et al.  Variable estimates of serum growth hormone concentrations by different radioassay systems. , 1988, The Journal of clinical endocrinology and metabolism.

[29]  Darrell M. Wilson,et al.  Levels of insulin-like growth factors I and II in infants with idiopathic macrosomia and infants of diabetic mothers , 1986 .

[30]  F. Gomez,et al.  A human placental GH: increasing levels during second half of pregnancy with pituitary GH suppression as revealed by monoclonal antibody radioimmunoassays. , 1985, International journal of fertility.

[31]  P. Seeburg.  The human growth hormone gene family: nucleotide sequences show recent divergence and predict a new polypeptide hormone. , 1982, DNA.

[32]  R. Hintz,et al.  Modulation of homologous receptor concentrations: a sensitive radioassay for human growth hormone in acromegalic, newborn, and stimulated plasma. , 1980, The Journal of clinical endocrinology and metabolism.